This study is looking at how well the IRRAflow® Active Fluid Exchange System works compared to standard treatments for clearing blood from the brain after an intracranial hemorrhage (bleeding in the brain), or for treating brain infections like ventriculitis or intracranial abscess. The IRRAflow system helps by automatically irrigating (washing), draining, and monitoring pressure inside the brain. You might be able to join if you are at least 18 years old, have bleeding in your brain confirmed by a scan, and your doctor thinks this system could help you. The study will look at how much blood remains in your brain after 5 days and your recovery at 6 months. The current status of this study is unclear, and it plans to enroll 250 participants.

Study design

This is an observational study comparing the IRRAflow system to standard care, involving 250 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your recovery will be assessed at 6 months after the study begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.